FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016558077> ?p ?o ?g. }

• W3016558077 endingPage "334" @default.
• W3016558077 startingPage "327" @default.
• W3016558077 abstract "ABSTRACT BACKGROUND AND PURPOSE Suboptimal platelet inhibition by clopidogrel (clopidogrel resistance) may be associated with high rates of stent thrombosis and ischemic events. Our objective was to determine if ticagrelor, a P2Y 12 receptor inhibitor, can result in platelet inhibition in patients with clopidogrel resistance. METHODS A thromboelastography‐platelet mapping assay was used in all patients undergoing neuroendovascular procedures requiring oral clopidogrel. In patients with suboptimal platelet inhibition (<60%) on clopidogrel, ticagrelor was imitated after an oral bolus of 180 mg followed by 90 mg twice daily and the platelet mapping assay was repeated. The primary endpoint was hemorrhagic complications classified as major (hemoglobin decrease >5 g/dL or intracranial hemorrhage with deficits), minor (hemoglobin decrease 3‐5 g/dL or intracranial hemorrhage without residual deficits), or insignificant. RESULTS Suboptimal platelet inhibition on clopidogrel was seen in 70 of 106 patients undergoing neuroendovascular procedures. There was a significantly higher magnitude of platelet inhibition with ticagrelor compared with clopidogrel in patients with clopidogrel resistance (mean ± SD: 85.90 ± 10.74% vs. 29.26 ± 17.71%; P < .001); 50 of 70 patients showed optimal inhibition. Two patients had major (fatal) hemorrhagic events (both received either intravenous thrombolytics and/or eptifibatide infusion). Three patients had minor hemorrhagic events, and two patients had insignificant hemorrhagic events. Four of seven hemorrhagic events occurred in patients with optimal response to clopidogrel, two occurred in patients with suboptimal response to ticagrelor, and one occurred in a patient with optimal response to ticagrelor. CONCLUSIONS Oral ticagrelor can augment platelet inhibition in patients who have clopidogrel resistance." @default.
• W3016558077 created "2020-04-24" @default.
• W3016558077 creator A5005792942 @default.
• W3016558077 creator A5008146589 @default.
• W3016558077 creator A5015218820 @default.
• W3016558077 creator A5020049468 @default.
• W3016558077 creator A5024562292 @default.
• W3016558077 creator A5024800813 @default.
• W3016558077 creator A5024995200 @default.
• W3016558077 creator A5032713857 @default.
• W3016558077 creator A5037219182 @default.
• W3016558077 creator A5037838983 @default.
• W3016558077 creator A5053304989 @default.
• W3016558077 creator A5062731591 @default.
• W3016558077 creator A5068075333 @default.
• W3016558077 date "2020-04-17" @default.
• W3016558077 modified "2023-10-01" @default.
• W3016558077 title "The Effect of Ticagrelor on Platelet Reactivity in Patients with Clopidogrel Resistance Undergoing Neuroendovascular Procedures" @default.
• W3016558077 cites W1612528405 @default.
• W3016558077 cites W175512219 @default.
• W3016558077 cites W1927069821 @default.
• W3016558077 cites W1964457971 @default.
• W3016558077 cites W1972403581 @default.
• W3016558077 cites W1985018076 @default.
• W3016558077 cites W1990859903 @default.
• W3016558077 cites W2010398932 @default.
• W3016558077 cites W2010400244 @default.
• W3016558077 cites W2082272778 @default.
• W3016558077 cites W2085817407 @default.
• W3016558077 cites W2085869089 @default.
• W3016558077 cites W2096379851 @default.
• W3016558077 cites W2097074987 @default.
• W3016558077 cites W2103784120 @default.
• W3016558077 cites W2110897264 @default.
• W3016558077 cites W2115855594 @default.
• W3016558077 cites W2118895431 @default.
• W3016558077 cites W2126493359 @default.
• W3016558077 cites W2130607817 @default.
• W3016558077 cites W2132793593 @default.
• W3016558077 cites W2140501627 @default.
• W3016558077 cites W2160351087 @default.
• W3016558077 cites W2160678403 @default.
• W3016558077 cites W2161055506 @default.
• W3016558077 cites W2169387542 @default.
• W3016558077 cites W2170312517 @default.
• W3016558077 cites W2322786744 @default.
• W3016558077 cites W2325378143 @default.
• W3016558077 cites W2361921955 @default.
• W3016558077 cites W2461238496 @default.
• W3016558077 cites W2514376554 @default.
• W3016558077 cites W2615022822 @default.
• W3016558077 cites W2624916373 @default.
• W3016558077 cites W2772677060 @default.
• W3016558077 cites W2780372032 @default.
• W3016558077 cites W2791225080 @default.
• W3016558077 cites W2979622327 @default.
• W3016558077 cites W2980546063 @default.
• W3016558077 doi "https://doi.org/10.1111/jon.12714" @default.
• W3016558077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32301181" @default.
• W3016558077 hasPublicationYear "2020" @default.
• W3016558077 type Work @default.
• W3016558077 sameAs 3016558077 @default.
• W3016558077 citedByCount "8" @default.
• W3016558077 countsByYear W30165580772020 @default.
• W3016558077 countsByYear W30165580772021 @default.
• W3016558077 countsByYear W30165580772022 @default.
• W3016558077 countsByYear W30165580772023 @default.
• W3016558077 crossrefType "journal-article" @default.
• W3016558077 hasAuthorship W3016558077A5005792942 @default.
• W3016558077 hasAuthorship W3016558077A5008146589 @default.
• W3016558077 hasAuthorship W3016558077A5015218820 @default.
• W3016558077 hasAuthorship W3016558077A5020049468 @default.
• W3016558077 hasAuthorship W3016558077A5024562292 @default.
• W3016558077 hasAuthorship W3016558077A5024800813 @default.
• W3016558077 hasAuthorship W3016558077A5024995200 @default.
• W3016558077 hasAuthorship W3016558077A5032713857 @default.
• W3016558077 hasAuthorship W3016558077A5037219182 @default.
• W3016558077 hasAuthorship W3016558077A5037838983 @default.
• W3016558077 hasAuthorship W3016558077A5053304989 @default.
• W3016558077 hasAuthorship W3016558077A5062731591 @default.
• W3016558077 hasAuthorship W3016558077A5068075333 @default.
• W3016558077 hasConcept C126322002 @default.
• W3016558077 hasConcept C164705383 @default.
• W3016558077 hasConcept C2777628954 @default.
• W3016558077 hasConcept C2777664302 @default.
• W3016558077 hasConcept C2777849778 @default.
• W3016558077 hasConcept C2780400711 @default.
• W3016558077 hasConcept C2780890252 @default.
• W3016558077 hasConcept C2781056559 @default.
• W3016558077 hasConcept C35294091 @default.
• W3016558077 hasConcept C42219234 @default.
• W3016558077 hasConcept C49059817 @default.
• W3016558077 hasConcept C500558357 @default.
• W3016558077 hasConcept C71924100 @default.
• W3016558077 hasConcept C89560881 @default.
• W3016558077 hasConceptScore W3016558077C126322002 @default.
• W3016558077 hasConceptScore W3016558077C164705383 @default.
• W3016558077 hasConceptScore W3016558077C2777628954 @default.

• next